Table 1. Characteristics of patients and samples.
| Location | Lung | Prostate | Breast | Colorectum | Pancreas | Blood | Brain | Overall (test set) | Pancreas (validation) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specimens | T | N | T | N | T | N | T | N | T | N | T | N | T | N | T | N | T | N |
| Number | 14 | 15 | 12 | 5 | 10 | 10 | 21 | 12 | 11 | 7 | 10 | 5 | 5 | - | 83 | 54 | 48 | 30 |
| Sex | ||||||||||||||||||
| Male | 10 | 9 | 12 | 5 | - | - | 13 | 6 | 9 | 5 | 2 | 0 | - | - | 46 | 25 | 31 | 18 |
| Female | 4 | 6 | - | - | 10 | 10 | 8 | 6 | 2 | 1 | 8 | 5 | - | - | 32 | 28 | 17 | 8 |
| na | - | - | - | - | - | - | - | - | - | 1 | - | - | 5 | - | 5 | 1 | - | 4 |
| Age, years | ||||||||||||||||||
| Mean | 61 | 53 | 64 | 63 | 60 | 60 | 56 | 61 | 63 | 53 | 49 | 38 | na | - | 59 | 55 | 64 | 49 |
| Range | 48–76 | 22–69 | 51–71 | 57–71 | 44–66 | 44–66 | 25–72 | 34–85 | 40–82 | 37–66 | 41–57 | 21–54 | na | - | 25–82 | 21–85 | 44–81 | 16–98 |
| Stage grouping * | ||||||||||||||||||
| 0 | - | - | - | - | - | - | - | - | - | - | 1 | - | - | - | 1 | - | - | - |
| I | 7 | - | - | - | 2 | - | 4 | - | - | - | 3 | - | - | - | 16 | - | - | - |
| II | - | - | 3 | - | 3 | - | 10 | - | 1 | - | 5 | - | - | - | 22 | - | 33 | - |
| III | 7 | - | 8 | - | 3 | - | 2 | - | 7 | - | - | - | - | - | 27 | - | 7 | - |
| IV | - | - | 1 | - | 2 | - | 3 | - | 3 | - | 1 | - | - | - | 10 | - | 7 | - |
| na | - | - | - | - | - | - | 2 | - | - | - | - | - | 5 | - | 7 | - | 1 | - |
T: Tumor; N: Normal; na: data not available
*
For CLL, Rai staging is shown [15].